Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine

Since the emergence of the so-called omics technology, thousands of putative biomarkers have been identified and published, which have dramatically increased the opportunities for developing more effective therapeutics. These opportunities can have profound benefits for patients and for the economic... View More